Search

everythinglearnresearchcommunity

for

Search:↓

Trichoscopy shows hair diameter variability, vellus hairs, and the peripilar sign are key indicators for diagnosing Androgenetic Alopecia.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

Chronic scalp pain in trichodynia involves both body-wide and localized increased pain sensitivity.

Non-invasive methods can effectively diagnose and manage alopecia areata.

A woman's hair loss was due to trichotillomania, which is often misdiagnosed and can require different treatments based on age and underlying conditions.

Platelet-rich plasma therapy's effectiveness for female hair loss needs more accurate data and further examination.

Understanding hair follicle anatomy helps diagnose hair disorders.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

PRP and HF-MSCs treatment improves hair growth, thickness, and density in androgenetic alopecia.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

No cure for female pattern hair loss, but various effective treatments exist.

Hair loss in males involves inflammation, collagen buildup, and follicle damage, with severity increasing with age and baldness duration.

Male hormones affect oil-producing skin cells differently based on their body location, and the drug spironolactone can reduce these effects.

The conclusion is that the best approach for treating Female Pattern Hair Loss is a combination of different treatments.

The antiandrogen 11α-hydroxyprogesterone effectively reduces skin oil and cholesterol when applied to the skin.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Recent advances in hair loss treatments show significant progress.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

The modified wash test is better than TrichoScan® for diagnosing hair loss.

Several new treatments for different types of hair loss show promise in improving patient quality of life.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

Topical spironolactone effectively treats hair loss in women.

Hair loss improved with treatment and successful transplant.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.